Impact of the COVID-19 pandemic on tuberculosis national reference laboratory services in the WHO European Region, March to November 2020

Maurer, Florian P.; Shubladze, Natalia; Kalmambetova, Gulmira; Felker, Irina; Kuchukhidze, Giorgi; Drobniewski, Francis; Yedilbayev, Askar; Ehsani, Soudeh

doi:10.2807/1560-7917.es.2021.26.24.2100426

Cited by 11 publications

(6 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Nineteen publications [56][57][58][59][60][61][62][63][64][65][66][67][68][69][70][71][72][73][74] focused on COVID-19's detrimental impacts on TB diagnosis, laboratory capacity and systems, and the supply chain.…”

Section: Diagnosis and Laboratory Systemsmentioning

confidence: 99%

“…Mauer, et al (73) detailed a WHO survey of 31 national TB reference laboratories in the European Union and the United Kingdom, reporting that COVID-19-related disruptions to TB laboratory services peaked from March to June 2020. The core laboratory setbacks were: 1) sample turnaround time; 2) access to external quality assessment; and 3) availability of diagnostic services.…”

Section: Diagnosis and Laboratory Systemsmentioning

confidence: 99%

See 1 more Smart Citation

The Global Impact of COVID-19 on Tuberculosis: A Thematic Scoping Review, 2020-2023

Marco,

Ahmedov,

Castro

2024

Preprint

View full text Add to dashboard Cite

Background: This thematic scoping review of publications sought to understand the global impact of COVID-19 on tuberculosis (TB), interpret the scope of resonating themes, and offer policy recommendations to stimulate TB recovery and future pandemic preparedness. Data Sources: Publications were captured from three search engines, PubMed, EBSCO, and Google Scholar, and applicable websites written in English from January 1, 2020, to April 30, 2023. Study Selection: Our scoping review was limited to publications detailing the impact of COVID-19 on TB. Original research, reviews, letters, and editorials describing the deleterious and harmful––yet sometimes positive–– impact of COVID-19 (sole exposure) on TB (sole outcome) were included. The objective was to methodically categorize the impacts into themes through a comprehensive review of selected studies to provide significant health policy guidance. Data Extraction: Two authors independently screened citations and full texts, while the third arbitrated when consensus was not met. All three performed data extraction. Data Synthesis/Results: Of 1,755 screened publications, 176 (10%) covering 39 countries over 41 months met the inclusion criteria. Ten principal themes were established, which encompassed TB’s care cascade, patient-centered care, psychosocial issues, and health services: 1) case-finding and notification (n=45; 26%); 2) diagnosis and laboratory systems (n=19; 10.7%) 3) prevention, treatment, and care (n=22; 12.2%); 4) telemedicine/telehealth (n=12; 6.8%); 5) social determinants of health (n=14; 8%); 6) airborne infection prevention and control (n=8; 4.6%); 7) health system strengthening (n=22; 13%); 8) mental health (n=13; 7.4%); 9) stigma (n=11; 6.3%); and 10) health education (n=10; 5.7%). Limitations: Heterogeneity of publications within themes. Conclusions: We identified ten globally generalizable themes of COVID-19’s impact on TB. These thematic areas will guide evidence-informed policies to strengthen comprehensive global responses, recovery for TB, and future airborne pandemic preparedness.

show abstract

Section: Diagnosis and Laboratory Systemsmentioning

confidence: 99%

Section: Diagnosis and Laboratory Systemsmentioning

confidence: 99%

The Global Impact of COVID-19 on Tuberculosis: A Thematic Scoping Review, 2020-2023

Marco,

Ahmedov,

Castro

2024

Preprint

View full text Add to dashboard Cite

show abstract

“…Coronavirus (COVID-19) is a communicable disease that produces severe morbidity and mortality around the globe and more than three million people died due to COVID-19 [ 1 ]. COVID-19 infection and risk of death is increasing in people who have had chronic diseases like diabetes mellitus, hypertension, and other immunity suppressive diseases [ 2 , 3 ].…”

Section: Introductionmentioning

confidence: 99%

COVID-19 vaccine acceptability and determinants among pregnant mothers attending antenatal care services at Debre Markos town public health institutions, Debre Markos Northwest Ethiopia: mixed study

Aynalem¹,

Melesse²,

Zeleke³

2022

Pan Afr Med J

View full text Add to dashboard Cite

Introduction coronavirus is a communicable disease that produces severe morbidity and mortality in the globe and more than three million people died due to COVID-19. Pregnant mothers are at higher risk of COVID-19 viral infection, with great morbidity and mortality. Thus, the purpose of this research is to assess the level of COVID-19 vaccine acceptability, determinants, and hesitancy among pregnant mothers attending antenatal care at Debre Markos town, public health institutions, Debre Markos, Northwest Ethiopia. Methods a mixed study was conducted among 350 pregnant mothers attending antenatal care at Debre Markos town health institutions and the participants were selected by consecutive sampling techniques. The collected data were entered into EPI Info version 7 and then exported to SPSS version 25 for data cleaning and analysis. The level of COVID-19 vaccine acceptability was determined through descriptive statistics, whereas its determinants were identified by binary logistic regression analyses. Variables with p-value < 0.05 in multivariable were considered as significantly associated factors. The qualitative data were collected by an unstructured interviewer guide using in-depth interview data collection methods. Study participants were selected purposively until the required data was saturated. The data was analysed under selected themes based on the guide and summarized manually. Results sixty-five (18.5%) of the respondents accept the COVID-19 vaccine [95% CI: 13, 23]. Maternal age [AOR: 3.281 (95% CI: 1.184, 9.092)], chronic medical illness [AOR: 0.170 (95% CI: 0.051, .562)], information about COVID-19 vaccine [AOR: 4.063 (95% CI: 1.462, 11.293)], pregnancy-induced medical conditions [AOR: 4.131 (95% CI: 1.055, 16.183) were identified as significant determinants of COVID-19 vaccine acceptability. From the quantitative wing. The qualitative finding implied that misconception, fear of medical complications, lack of trust in its effectiveness, and religious constraints were the common reasons for vaccine hesitancy. Conclusion COVID-19 vaccine acceptability by pregnant mothers attending ANC at Debre Markos town public health institutions is very low. The health care providers and health extension workers shall create information about the COVID-19 vaccine on its importance and side effects.

show abstract

“…In the World Health Organization’s (WHO) European Region, apart from public health measures to reduce transmission and managing capacity of hospital care, restructuring national testing and treatment monitoring for human immunodeficiency virus (HIV), tuberculosis (TB), viral hepatitis, and sexually transmitted infections (STI) and maximising the use of available resources in a short timeframe was a necessity in ensuring a swift response to the COVID-19 pandemic. Measures taken included reallocation of staff and equipment from TB, HIV, and other viral diagnostic services to SARS-CoV-2 testing [ 3 ]. Countries showed varying degrees of success in this restructuring and reallocation, depending on national infrastructure, staff skills and global shortages of key equipment, kits reagents and consumables [ 4 , 5 ].…”

Section: Introductionmentioning

confidence: 99%

Integrated use of laboratory services for multiple infectious diseases in the WHO European Region during the COVID-19 pandemic and beyond

et al. 2022

Self Cite

View full text Add to dashboard Cite

Technical advances in diagnostic techniques have permitted the possibility of multi-disease-based approaches for diagnosis and treatment monitoring of several infectious diseases, including tuberculosis (TB), human immunodeficiency virus (HIV), viral hepatitis and sexually transmitted infections (STI). However, in many countries, diagnosis and monitoring, as well as disease response programs, still operate as vertical systems, potentially causing delay in diagnosis and burden to patients and preventing the optimal use of available resources. With countries facing both human and financial resource constraints, during the COVID-19 pandemic even more than before, it is important that available resources are used as efficiently as possible, potential synergies are leveraged to maximise benefit for patients, continued provision of essential health services is ensured. For the infectious diseases, TB, HIV, hepatitis C (HCV) and STI, sharing devices and integrated services starting with rapid, quality-assured, and complete diagnostic services is beneficial for the continued development of adequate, efficient and effective treatment strategies. Here we explore the current and future potential (as well as some concerns), importance, implications and necessary implementation steps for the use of platforms for multi-disease testing for TB, HIV, HCV, STI and potentially other infectious diseases, including emerging pathogens, using the example of the COVID-19 pandemic.

show abstract

Impact of the COVID-19 pandemic on tuberculosis national reference laboratory services in the WHO European Region, March to November 2020

Cited by 11 publications

References 10 publications

The Global Impact of COVID-19 on Tuberculosis: A Thematic Scoping Review, 2020-2023

The Global Impact of COVID-19 on Tuberculosis: A Thematic Scoping Review, 2020-2023

COVID-19 vaccine acceptability and determinants among pregnant mothers attending antenatal care services at Debre Markos town public health institutions, Debre Markos Northwest Ethiopia: mixed study

Integrated use of laboratory services for multiple infectious diseases in the WHO European Region during the COVID-19 pandemic and beyond

Contact Info

Product

Resources

About